Nightline Video shows IPV-1C® being used to treat H1N1 patients
In the first section you can see an IPV-1C® by the patient and in the second the patient is being given a treatment.
Click here to see the segment>>
Concerns continue over H1N1
To hear Respiratory Care & Sleep Medicine's H1N1 Flu Roundtable
Click here >>
H1N1: IPV improves on HFOV in Central Illinois Hospital< <click here > >
Dr. Bird receives second National Medal
Dr. Forrest M. Bird received the National Medal of Technology and Innovation from President Barack Obama on October 7, 2009 after having received the Presidential Citizens Medal from then President George W. Bush on December 10, 2008. Click here to see the presentaion on YouTube>>
Bird receives national honor
Sagle man given Presidential Citizens Medal Read Article>>
Dr. Forrest M. Bird Speaking at the SCCM Lecture
Click on the MP3 player below to listen.
PERCUSSIONAIRE® Corporation PERCUSSIONATOR® Ventilators with integrated Lung Protective Strategies.
The Fourth Generation of Aeromedical Devices Conceived by:Forrest M Bird, M.D., PhD., ScD...
THE SUN NEVER SETS ON WORLD WIDE PATIENTS USING PERCUSSIONAIRE® CORPORATION PRODUCTS.
AN INTRODUCTION TO PERCUSSIONAIRE® CORPORATION'S HOSPITAL AND HOME BREATHING RESPIRATORS.
The Percussionaire® Corporation manufactures and distributes the fourth generation of Dr. Bird’s INTRAPULMONARY PERCUSSIVE VENTILATION (IPV®) and VOLUMETRIC DIFFUSIVE RESPIRATION (VDR®) PERCUSSIONATORS® AS WELL AS THEIR DERIVATIVES AND ASSOCIATED ACCESSORIES.
AN EXPANDED HISTORICAL REVIEW OF DR. BIRD’s CARDIO-PULMONARY VENTILATORY MANAGEMENT CONTRIBUTIONS FROM WW II THROUGH 2009
This document employs the existing pathophysiology of patients with various cardiopulmonary compromises in determining the most effective type of mechanical ventilation for lung and circulatory recruitment and ventilatory maintenance. The use of volume-pressure oriented CMV maintenance ventilation is compared to Intrapulmonary Percussive Ventilation (IPV®), which was conceived and developed for alveolar and intrathoracic circulatory recruitment and ventilatory maintenance with a lung protective strategy.
